Product on sale

Symtuza (Darunavir/Cobicistat/Emtricitabine/TAF)

Original price was: $4,200.Current price is: $4,000.

20 products sold in last 6 hours
Selling fast! Over 13 people have in their cart

Symtuza offers complete HIV treatment in a single tablet, combining a protease inhibitor with three powerful antiviral boosters.

28 people are viewing this right now
  • Estimated Delivery : Up to 4 business days
  • Free Shipping & Returns : On all orders over $200
Guaranteed Safe And Secure Checkout

Symtuza merges darunavir, cobicistat, emtricitabine, and tenofovir alafenamide (TAF) into one convenient tablet.
It’s a full antiretroviral therapy (ART) solution designed for adults and adolescents with HIV-1 infection.
The protease inhibitor (darunavir) blocks viral replication, while cobicistat enhances drug levels for better effectiveness.
Symtuza maintains durable viral suppression and supports immune system recovery.
It’s taken once daily with food and is well-tolerated by most users.
Regular monitoring of liver and kidney function is advised during therapy.
Symtuza is valued for its convenience, efficacy, and long-term safety profile.

Related products